Het effect van coblatie behandeling op kraakbeen kwaliteit

The effect of coblation treatment on knee cartilage quality in patients with meniscal lesions and cartilage loosening of the knee

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON26079

Enrollment

Registered

2019-03-12

Start date

2019-05-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

meniscal injury and cartilage loosening.

Interventions

Coblation treatment during knee arthroscopy

Eligibility

Inclusion criteria

Inclusion criteria: - focal cartilage lesions, ICRS grade 2-3a (i.e. partial thickness) (Brittberg and Peterson, 1998) - age =18y

Exclusion criteria

Exclusion criteria: - subjects with general contraindications for MRI scanning - a known allergic reaction to gadolinium-containing contrast agents - renal insufficiency (glomerular filtration rate, <60 mL/min) - Subjects who do not understand Dutch written language, necessary for completing the PROMS

Design outcomes

Primary

Measure	Time frame
The primary outcome is the dGEMRIC index (T1gd, in ms) at one year follow-up of the treated region	—

Secondary

Measure	Time frame
- T1gd (ms) at healthy regions surrounding the treated area will be measured for reference - Patient reported outcome of knee function, quality of life and pain will be collected preoperatively, and at 3, 6 and 12 months	—

Contacts

Public ContactMenno Benard

Alrijne Ziekenhuis

mrbenard@alrijne.nl0715829773

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)